Peripheral Arterial Disease Market Forecast 2025-2034: Comprehensive Analysis And Growth Opportunities

The Peripheral Arterial Disease Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Projected Growth of the Peripheral Arterial Disease Market?
The market size of peripheral arterial disease has witnessed significant expansion in the past few years. The market, which is predicted to surge from a valuation of $4.36 billion in 2024 to $4.76 billion in 2025, reflects a compound annual growth rate (CAGR) of 9.2%. This substantial growth during the historic period is ascribed to numerous factors such as the advent of innovative medical devices, advances in gene therapy and regenerative medicine, breakthroughs in pharmacogenomics, as well as the flourishing of digital health and remote monitoring.

In the upcoming years, the size of the peripheral arterial disease market is anticipated to witness robust growth, reaching $6.62 billion by 2029 with an 8.6% compound annual growth rate (CAGR). The growth over the forecast period can be credited to factors such as interdisciplinary care teams, minimally invasive interventions, and the role of lifestyle and exercise prescriptions. Future trends expected to make a significant impact in this period are vascular tele-rehabilitation, multimodal pain management, advancements in wound care, along with public health campaigns.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12999

What Are the Different Peripheral Arterial Disease Market Segments?
The peripheral arterial disease market covered in this report is segmented -

1) By Treatment Type: Devices, Catheters, Drugs, Other Types
2) By Route of Administration: Oral, Parenteral, Other Route of Administrations
3) By End User: Hospitals, Specialty Clinics, Others End-Users

Subsegments:
1) By Devices: Stents, Balloons, Atherectomy Devices
2) By Catheters: Drug-Eluting Catheters, Balloon Catheters, Guidewires
3) By Drugs: Antiplatelet Agents, Anticoagulants, Vasodilators
4) By Other Types: Surgical Interventions, Lifestyle Modification Programs, Endovascular Therapy

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12999&type=smp

What Are the Primary Drivers Shaping the Peripheral Arterial Disease Market?
The escalating incidence of cardiac diseases is a key factor propelling the expansion of the peripheral arterial disease market. Essentially, cardiac disease affects the main veins supplying blood to the heart muscle, and the treatment of peripheral arterial disease proves beneficial to cardiac patients by enhancing blood circulation, reducing cardiovascular risk, alleviating symptoms, and improving the quality of life. For example, a report from the Australian Bureau of Statistics (ABS) from December 2023 revealed that in 2022, one in twenty individuals, or about 5.2% (roughly 1.3 million people), suffered from heart-related, stroke, and vascular diseases. Furthermore, in April 2022, the American College of Cardiology, a nonprofit medical association in the US, anticipated that the risk factors for ischemic heart disease would climb by 30.7% to 29 million by 2025. As a result, the escalating incidence of cardiac diseases is pushing the peripheral arterial disease market. Peripheral Arterial Disease Market Driving Force: The Increasing Prevalence Of Diabetes Is Expected To Grow The Peripheral Arterial Diseases

Which Companies Are Leading in the Peripheral Arterial Disease Market?
Major companies operating in the peripheral arterial disease market are Cardinal Health Inc., Johnson and Johnson Limited, Abbott Laboratories, Medtronic PLC, Becton Dickinson and Company, Koninklijke Philips N.V., Boston Scientific Corporation, B. Braun SE, Terumo Corp., Cook Medical LLC, Penumbra Inc., Shockwave Medical Inc., AngioDynamics Inc., Cardiovascular Systems Inc., ACIST Medical Systems Inc., SurModics Inc., Endologix Inc., BioVentrix Inc., QT Vascular Ltd., Avinger Inc., Mercator MedSystems Inc., VentureMed Group Ltd., Eximo Medical Ltd., LimFlow SA, Contego Medical LLC.

What Are the Major Trends Shaping the Peripheral Arterial Disease Market?
Leading firms in the peripheral arterial disease market are striving to advance treatment effectiveness, patient results, and to hasten recovery rates of individuals with vascular conditions by engineering groundbreaking medical equipment, such as an intravascular lithotripsy (IVL) catheter. This medical apparatus is employed to address calcified arterial blockages by propagating regulated shockwaves to fragment the calcium, aiding in restoring circulation and enhancing the suppleness of the vessel during procedures like angioplasty. For example, Shockwave Medical, Inc., a U.S. medical tech corporation, introduced the Shockwave E8 peripheral IVL catheter in September 2024. This equipment, specifically designed for the treatment of peripheral arterial disease, enables targeted intravascular lithotripsy, utilizing sonic waves to shatter calcium buildups in arterial walls. This innovative strategy assists in reviving blood flow while lessening potential damage to adjacent tissues. The catheter's superior architecture facilitates more manageable traversal through intricate vascular structures, rendering it fitting for a broad patient demographic.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/peripheral-arterial-disease-global-market-report

What Are the Top Revenue-Generating Geographies in the Peripheral Arterial Disease Market?
North America was the largest region in the peripheral artery disease market in 2024. The regions covered in peripheral artery disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Peripheral Arterial Disease Market?
2. What is the CAGR expected in the Peripheral Arterial Disease Market?
3. What Are the Key Innovations Transforming the Peripheral Arterial Disease Industry?
4. Which Region Is Leading the Peripheral Arterial Disease Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.